Raphael Pharmaceutical Inc. (RAPH) Operating cash flow 2020–2025
Raphael Pharmaceutical Inc. (RAPH) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$210,000FY2025 · since FY2020: -$779,000 → -$210,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$210,000 | +60.5% |
| FY2024 | -$532,000 | +55.8% |
| FY2023 | -$1.2M | -58.5% |
| FY2022 | -$759,000 | +46.5% |
| FY2021 | -$1.4M | -82.2% |
| FY2020 | -$779,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice